PRJNA720653
Late relapse and reinfection in HCV patients treated with direct-acting antiviral (DAA) drugs
HCV characterization by NGS with the aim to distinguish between late relapse and reinfection in patients showing late HCV RNA recurrence after more than 6 monthsof SVR.